New program aims to protect HIV patients from HPV cancer
NCT ID NCT05065840
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a program to help HIV-positive adults get the HPV vaccine, which can prevent HPV-related cancers. The program gives clinics and staff tools to encourage vaccination. Researchers will track how many people start and finish the vaccine series over two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CDC 4 Pillars Program (a behavioral intervention to increase vaccination uptake)
What this could lead to
If successful, this program could become a model for boosting HPV vaccination rates in high-risk HIV populations, potentially reducing HPV-related cancers.
What could go wrong
This is an implementation study, not a test of the vaccine itself. Success depends on clinics and patients following through, and results may not apply to other regions or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AHF Lithonia
Lithonia, Georgia, 30058, United States
-
AID Atlanta
Atlanta, Georgia, 30309, United States
-
Albany Rural Model Clinic
Albany, Georgia, 31705, United States
-
Faebris
Atlanta, Georgia, 30311, United States